SPDR SERIES TRUST - S&P BIOTECH (XBI)

CUSIP: 78464A870

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / S&P BIOTECH
Total 13F shares
134,408,588
Share change
-347,045
Total reported value
$16,389,593,622
Put/Call ratio
202%
Price per share
$121.93
Number of holders
801
Value change
-$13,936,707
Number of buys
416
Number of sells
252

Quarterly Holders Quick Answers

What is CUSIP 78464A870?
CUSIP 78464A870 identifies XBI - SPDR SERIES TRUST - S&P BIOTECH in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q4 2025

As of 31 Dec 2025, SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by 801 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 134,408,588 shares. The largest 10 holders included GOLDMAN SACHS GROUP INC, BNP PARIBAS FINANCIAL MARKETS, BANK OF AMERICA CORP /DE/, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, CITIGROUP INC, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, JPMORGAN CHASE & CO, UBS Group AG, and Avoro Capital Advisors LLC. This page lists 802 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.